| Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer New England Journal of Medicine 377 (20), 1919-1929, 2017 | 4011 | 2017 |
| Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC SJ Antonia, SJ (Antonia, [3] Villegas, A (Villegas, A.) [2], ... New England Journal of Medicine 379 (24), 2342-2350, 2018 | 2608 | 2018 |
| Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer [2] Colombo, N (Colombo, N.) [1], C Dubot, C (Dubot, ... New England Journal of Medicine 385 (20), 1856-1867, 2021 | 544 | 2021 |
| Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice A Squassina, M Manchia, VG Manolopoulos, M Artac, C Lappa-Manakou, ... Pharmacogenomics 11 (8), 1149-1167, 2010 | 176 | 2010 |
| Effect of first-line serplulimab vs placebo added to chemotherapy on survival in patients with extensive-stage small cell lung cancer: the ASTRUM-005 randomized clinical trial Y Cheng, L Han, L Wu, J Chen, H Sun, G Wen, Y Ji, M Dvorkin, J Shi, ... Jama 328 (12), 1223-1232, 2022 | 137 | 2022 |
| Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy H Bozcuk, G Uslu, M Samur, M Yıldız, T Özben, M Özdoğan, M Artaç, ... Cytokine 27 (2-3), 58-65, 2004 | 122 | 2004 |
| “Do not tell”: what factors affect relatives’ attitudes to honest disclosure of diagnosis to cancer patients? M Ozdogan, M Samur, HS Bozcuk, E Coban, M Artac, B Savas, A Kara, ... Supportive care in cancer 12, 497-502, 2004 | 118 | 2004 |
| Factors related to truth-telling practice of physicians treating patients with cancer in Turkey M Ozdogan, M Samur, M Artac, M Yildiz, B Savas, HS Bozcuk Journal of palliative medicine 9 (5), 1114-1119, 2006 | 81 | 2006 |
| Does maintenance/consolidation chemotherapy have a role in the management of small cell lung cancer (SCLC)? A metaanalysis of the published randomized controlled trials H Bozcuk, M Artac, M Ozdogan, B Savas Cancer: Interdisciplinary International Journal of the American Cancer …, 2005 | 75 | 2005 |
| Demographics, Clinical Presentations and Outcomes of Cancer Patients Admitting to Emergency Department. N Bozdemir, O Eray, C Eken, Y Şenol, M Artac, M Samur Turkish Journal of Medical Sciences 39 (2), 235-240, 2009 | 74 | 2009 |
| Leptin and breast cancer: an overview M Artac, K Altundag Medical oncology 29, 1510-1514, 2012 | 69 | 2012 |
| Does music exposure during chemotherapy improve quality of life in early breast cancer patients? A pilot study H Bozcuk1ABCDEF, M Artac1ABDF, A Kara2B, M Ozdogan1BD, ... Med Sci Monit 12 (5), 205, 2006 | 59 | 2006 |
| Durable remission of leptomeningeal metastasis of breast cancer with letrozole: a case report and implications of biomarkers on treatment selection M Ozdogan, M Samur, HS Bozcuk, E Sagtas, M Yildiz, M Artac, B Savas Japanese journal of clinical oncology 33 (5), 229-231, 2003 | 59 | 2003 |
| Epidemiology of colorectal cancer in Turkey: A cross-sectional disease registry study (A Turkish Oncology Group trial) N Aykan, Ş YALÇIN, N Turhal, M Ozdogan, G Demir, M Özkan, A Yaren, ... Turkish Journal of Gastroenterology 26 (2), 2015 | 46 | 2015 |
| The relationship between nutritional status and handgrip strength in adult cancer patients: a cross-sectional study ŞB Alkan, M Artaç, N Rakıcıoğlu Supportive Care in Cancer 26, 2441-2451, 2018 | 42 | 2018 |
| Gene methylation of SFRP2, P16, DAPK1, HIC1, and MGMT and KRAS mutations in sporadic colorectal cancer S Pehlivan, M Artac, T Sever, H Bozcuk, C Kilincarslan, M Pehlivan Cancer genetics and cytogenetics 201 (2), 128-132, 2010 | 42 | 2010 |
| Quality of life in patients with advanced non-small cell lung cancer H Bozcuk, B Dalmis, M Samur, M Ozdogan, M Artac, B Savas Cancer Nursing 29 (2), 104-110, 2006 | 42 | 2006 |
| A simple and accurate prediction model to estimate the intrahospital mortality risk of hospitalised cancer patients H Bozcuk, E Koyuncu, M Yildiz, M Samur, M ÖzdoǦan, M Artaç, E Çoban, ... International journal of clinical practice 58 (11), 1014-1019, 2004 | 41 | 2004 |
| Severe pulmonary haemorrhage accompanying hepatorenal failure in fulminant leptospirosis B Dursun, F Bostan, M Artac, HI Varan, G Suleymanlar International journal of clinical practice 61 (1), 164-167, 2007 | 40 | 2007 |
| The value of XPD and XRCC1 genotype polymorphisms to predict clinical outcome in metastatic colorectal carcinoma patients with irinotecan-based regimens M Artac, H Bozcuk, S Pehlivan, S Akcan, M Pehlivan, T Sever, M Ozdogan, ... Journal of cancer research and clinical oncology 136, 803-809, 2010 | 39 | 2010 |
